Organon & Co.

Equity-NMS: OGN

Healthcare | Drug Manufacturers - General

$5.85-0.2 (March 27, 2026)

Organon & Co. Chart

Organon & Co. Performance

Days Range

Previous Close: $6.05
Open: $6.1
EPS(TTM): 0.72
Shares O/S: 260.32 M
Day's Range$5.84 - $6.15
52W Range$5.76 - $14.7925
Market Cap1.52 B

About Organon & Co.

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Frequently Asked Questions

Organon & Co. (OGN) share price as of March 28, 2026 is $5.85. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Organon & Co. (OGN) Share by opening an international trading account with Angel One.
Purchasing Organon & Co. (OGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Organon & Co. (OGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Organon & Co. (OGN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Organon & Co. on February 11, 2026, is $1.52 B.
Organon & Co. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
In order to invest in Organon & Co. (OGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers